BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15929116)

  • 1. Lymphocytic pneumonitis as the manifestation of acute graft-versus-host disease of the lung.
    Bolaños-Meade J; Ioffe O; Hey JC; Vogelsang GB; Akpek G
    Am J Hematol; 2005 Jun; 79(2):132-5. PubMed ID: 15929116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports.
    Milgrom SA; Nieto Y; Pinnix CC; Smith GL; Wogan CF; Rondon G; Medeiros LJ; Kebriaei P; Dabaja BS
    J Med Case Rep; 2016 Jul; 10():209. PubMed ID: 27465468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation.
    Cutler C; Kim HT; Hochberg E; Ho V; Alyea E; Lee SJ; Fisher DC; Miklos D; Levin J; Sonis S; Soiffer RJ; Antin JH
    Biol Blood Marrow Transplant; 2004 May; 10(5):328-36. PubMed ID: 15111932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant.
    Kim JG; Sohn SK; Kim DH; Lee NY; Suh JS; Lee KS; Lee KB
    Eur J Haematol; 2004 Jul; 73(1):56-61. PubMed ID: 15182339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute graft-versus-host disease of the lung after liver transplantation.
    Knox KS; Behnia M; Smith LR; Vance GH; Busk M; Cummings OW; Kwo PY; Wilkes DS
    Liver Transpl; 2002 Oct; 8(10):968-71. PubMed ID: 12360443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
    Rosenbeck LL; Kiel PJ; Kalsekar I; Vargo C; Baute J; Sullivan CK; Wood L; Abdelqader S; Schwartz J; Srivastava S; Abonour R; Robertson MJ; Nelson RP; Cornetta K; Fausel CA; Farag SS
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):916-22. PubMed ID: 20932925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytic pneumonitis following bone marrow transplantation in severe combined immunodeficiency.
    Stein R; Hummel D; Bohn D; Levison H; Roifman CM
    Am Rev Respir Dis; 1991 Jun; 143(6):1406-8. PubMed ID: 2048828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute graft-versus-host disease of the lung with atypical presentation.
    Lin PC; Hsiao LT; Chen PM
    Int J Hematol; 2006 Jul; 84(1):1. PubMed ID: 16867893
    [No Abstract]   [Full Text] [Related]  

  • 9. A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.
    Yahng SA; Kim JH; Jeon YW; Yoon JH; Shin SH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Kim HJ
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):119-29. PubMed ID: 25300871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of graft-versus-host disease prophylaxis in reduced-intensity conditioning allogeneic stem cell transplant in acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Rubio MT; Labopin M; Blaise D; Socié G; Contreras RR; Chevallier P; Sanz MA; Vigouroux S; Huynh A; Shimoni A; Bulabois CE; Caminos N; López-Corral L; Nagler A; Mohty M
    Haematologica; 2015 May; 100(5):683-9. PubMed ID: 25769546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive chronic graft-versus-host disease of skin successfully treated with thalidomide.
    Nair V; Sharma A; Ghosh I; Arora S; Sahai K; Dutta V
    J Assoc Physicians India; 2005 Nov; 53():988-90. PubMed ID: 16515241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An acute pulmonary syndrome possibly representing acute graft-versus-host disease involving the lung interstitium.
    Atkinson K; Turner J; Biggs JC; Dodds A; Concannon A
    Bone Marrow Transplant; 1991 Sep; 8(3):231-4. PubMed ID: 1958905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chronic pulmonary syndrome associated with graft-versus-host disease after allogeneic marrow transplantation.
    Schwarer AP; Hughes JM; Trotman-Dickenson B; Krausz T; Goldman JM
    Transplantation; 1992 Dec; 54(6):1002-8. PubMed ID: 1465767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute cutaneous graft-versus-host disease resembling type II (atypical adult) pityriasis rubra pilaris.
    Surjana D; Robertson I; Kennedy G; James D; Weedon D
    Australas J Dermatol; 2015 Feb; 56(1):e21-3. PubMed ID: 25688705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease.
    Pidala J; Kim J; Alsina M; Ayala E; Betts BC; Fernandez HF; Field T; Jim H; Kharfan-Dabaja MA; Locke FL; Mishra A; Nishihori T; Ochoa-Bayona L; Perez L; Riches M; Anasetti C
    Haematologica; 2015 Jul; 100(7):970-7. PubMed ID: 25840599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between acute graft versus host disease and lung injury after allogeneic haematopoietic stem cell transplantation.
    Liu QF; Luo XD; Ning J; Xu D; Fan ZP; Sun J; Zhang Y; Xu B; Wei YQ
    Hematology; 2009 Apr; 14(2):63-72. PubMed ID: 19298716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sclerodermiform chronic graft-versus-host disease after allogenic peripheral blood stem-cell transplantation].
    Neid T; Danz B; Eismann R; Bramsiepe I; Wohlrab J; Marsch WC; Fiedler E
    Dtsch Med Wochenschr; 2009 May; 134(21):1106-9. PubMed ID: 19437374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus with mini-methotrexate as prophylaxis for graft-versus-host disease in pediatric patients after allogeneic peripheral blood stem cell transplant or bone marrow transplant.
    Sabapathy C; Gourde JA; Khan SP; Rodriguez V
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):945-9. PubMed ID: 19131788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late CD8+ lymphocytic alveolitis after allogeneic bone marrow transplantation and chronic graft-versus-host disease.
    Leblond V; Zouabi H; Sutton L; Guillon JM; Mayaud CM; Similowski T; Beigelman C; Autran B
    Am J Respir Crit Care Med; 1994 Oct; 150(4):1056-61. PubMed ID: 7921436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.